Literature DB >> 28315034

Natural History of Pancreatic Cysts.

Alexander Larson1, Richard S Kwon2.   

Abstract

Pancreatic cystic neoplasms are discovered with increasing frequency. Accurate knowledge of the natural history of cystic neoplasms is crucial to develop useful and cost-effective strategies for surveillance and surgical resection. To date, the natural history of cystic neoplasms is still incomplete due to lack of adequate diagnostic accuracy in the absence of surgical pathology. Nevertheless, current evidence points to risk factors for malignant transformation to help clinical management. New biomarkers that accurately distinguish cyst neoplasms and those most likely to progress to cancer would help clarify the natural history of cystic neoplasms.

Entities:  

Keywords:  Intraductal papillary mucinous neoplasm (IPMN); Mucinous cystic neoplasm; Natural history; Pancreatic cystic neoplasms; Serous cystadenoma

Mesh:

Substances:

Year:  2017        PMID: 28315034     DOI: 10.1007/s10620-017-4542-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  98 in total

1.  A natural course of main duct intraductal papillary mucinous neoplasm of the pancreas with lower likelihood of malignancy.

Authors:  Hiroyuki Uehara; Osamu Ishikawa; Kenji Ikezawa; Natsuko Kawada; Takuya Inoue; Rena Takakura; Yasuna Takano; Sachiko Tanaka; Akemi Takenaka
Journal:  Pancreas       Date:  2010-07       Impact factor: 3.327

2.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

4.  Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.

Authors:  Jennifer F Tseng; Andrew L Warshaw; Dushyant V Sahani; Gregory Y Lauwers; David W Rattner; Carlos Fernandez-del Castillo
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

Review 5.  Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.

Authors:  Neeraj Anand; Kartik Sampath; Bechien U Wu
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-13       Impact factor: 11.382

Review 6.  Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis.

Authors:  Stefano Crippa; Gabriele Capurso; Calogero Cammà; Gianfranco Delle Fave; Carlos Fernández-Del Castillo; Massimo Falconi
Journal:  Dig Liver Dis       Date:  2016-02-18       Impact factor: 4.088

7.  Estimation of the prevalence of asymptomatic pancreatic cysts in the population of San Marino.

Authors:  Nicola Zanini; Marco Giordano; Elia Smerieri; Giulio Cipolla d'Abruzzo; Marilyn Guidi; Giorgio Pazzaglini; Fiorella De Luca; Giorgia Chiaruzzi; Giovanni Vitullo; Paolo Piva; Raffaele Lombardi; Elio Jovine; Marino Gatti; Giovanni Landolfo
Journal:  Pancreatology       Date:  2015-05-21       Impact factor: 3.996

8.  An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Takao Ohtsuka; Hiroshi Kono; Yosuke Nagayoshi; Yasuhisa Mori; Kosuke Tsutsumi; Yoshihiko Sadakari; Shunichi Takahata; Katsuya Morimatsu; Shinichi Aishima; Hisato Igarashi; Tetsuhide Ito; Kousei Ishigami; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Surgery       Date:  2011-08-27       Impact factor: 3.982

9.  Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.

Authors:  Mari Mino-Kenudson; Carlos Fernández-del Castillo; Yoshifumi Baba; Nakul P Valsangkar; Andrew S Liss; Maylee Hsu; Camilo Correa-Gallego; Thun Ingkakul; Rocio Perez Johnston; Brian G Turner; Vasiliki Androutsopoulos; Vikram Deshpande; Deborah McGrath; Dushyant V Sahani; William R Brugge; Shuji Ogino; Martha B Pitman; Andrew L Warshaw; Sarah P Thayer
Journal:  Gut       Date:  2011-04-20       Impact factor: 23.059

10.  What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.

Authors:  Asma Sultana; Richard Jackson; Gilbert Tim; Emma Bostock; Eftychia E Psarelli; Trevor F Cox; Robert Sutton; Paula Ghaneh; Michael G T Raraty; John P Neoptolemos; Christopher M Halloran
Journal:  Clin Transl Gastroenterol       Date:  2015-12-10       Impact factor: 4.488

View more
  1 in total

1.  Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer.

Authors:  Bin Liu; Hai Yang; Leila Taher; Axel Denz; Robert Grützmann; Christian Pilarsky; Georg F Weber
Journal:  Transl Oncol       Date:  2018-04-06       Impact factor: 4.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.